JP2007175396A - Drug bag - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide a drug bag which is different in type from a conventional drug bag and calls the attention of a user so as to allow a correct operation to be performed. <P>SOLUTION: The drug bag (1) comprises a flexible bag body (2) where different drugs are sealed in a plurality of partitioned chambers (10, 12) divided with a weak seal part (8); an outlet member (16) attached to the bag body (2); an access block member (18) for blocking access to the outlet (14) of the outlet member (16) from an outer part; and a cover member (20) for blocking the detachment of the access block member (18) from the outlet member (16). The cover member (20) includes a pair of elements (20a, 20b), which are normally mutually connected so as to block the detachment of the access block member (18) and to prevent the discharge of the drug, and are disconnected by fluid pressure at the moment when the weak seal part (8) is opened by pressure from the outer part so as to permit the detachment of the access block member (18). <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

  The present invention relates to a drug bag, and more particularly, to a drug bag having a plurality of compartments and using the medicines enclosed in these compartments.

  Drug bags that contain drugs for infusion or dialysis, etc., are known that contain drugs in multiple compartments and allow these patients to be infused or dialyzed in a mixed state. Yes. At this time, if a plurality of drugs are mixed in advance, the properties of the mixed drugs may change with time. Therefore, it is necessary to mix a plurality of drugs immediately before infusion or dialysis.

  Such a conventional drug bag has a bag body in which two flexible films are bonded to each other, and the partition between the plurality of compartments that store the drug has a relatively high bonding strength. In addition to a weak weak seal portion, it further includes a discharge port member having a discharge port closed with a rubber plug that can be pierced with a puncture needle of an infusion set to discharge the drug. . When using the conventional medicine bag configured as above, the medicine in the compartment is pressurized from the outside to open the partition part (weak seal part) and mix a plurality of medicines. The puncture needle is inserted into a rubber plug, the mixed medicine is discharged from the discharge port, and it is administered to the patient.

  When using such a conventional drug bag, it is possible to inadvertently administer an unmixed drug to a patient without mixing a plurality of drugs.

  In order to prevent this, there is known a medicine bag in which a second weak seal portion having a low bonding strength is further provided in the bag body portion in front of the discharge port member (see, for example, Patent Document 1). In this medicine bag, when pressure is applied to the medicine from the outside to open the weak seal portion between the compartments, the second weak seal portion is continuously opened by the fluid pressure. Thereafter, when the puncture needle of the infusion set is inserted into a rubber plug, the mixed medicine is discharged from the discharge port.

  In addition, a cover that covers the entire discharge port member is provided, and pressure is applied to the drug bag from the outside to open the weak seal between the compartments, and the cover is discharged in conjunction with the fluid pressure generated thereby. There is known a medicine bag that can be removed from the outlet member (see, for example, Patent Document 2). In this drug bag, after the cover of the discharge port member is removed, the mixed drug is discharged from the discharge port by inserting the puncture needle of the infusion set into the rubber plug.

JP 2004-661 A International Publication No. 2005/97039 Pamphlet

  The above-described drug bag prevents unmixed drugs from being administered to the patient.

  On the other hand, there is a demand for a drug bag that is different from the above-described conventional liquid bag and similarly prevents an unmixed drug from being administered to a patient. In this case, it is desirable that the attention of a user such as a nurse or a nurse can be raised as much as possible in order to reliably prevent an unmixed drug from being administered to a patient.

  Then, this invention is providing the chemical | medical agent bag which can call the attention of users, such as a nurse, so that correct operation may be performed by the type different from the conventional chemical | medical agent bag.

  In order to achieve the above object, a drug bag according to the present invention has a plurality of compartments, and is a medicine bag that is used by mixing medicines enclosed in these compartments, and is formed of a flexible material. The internal cavity is divided into a plurality of compartments by weak seals, and each compartment is filled with a different type of medicine, and the bag is attached to the bag body and opens into one of the compartments. A discharge port member that constitutes a discharge port for discharging the medicine to the outside, an access blocking member that covers the discharge port of the discharge port member and blocks external access, and an access blocking member that covers the access blocking member And a cover member that prevents removal from the discharge port member, and the cover member is attached to sandwich a part of the compartment in which the discharge port member and the discharge port of the bag body are formed from both sides. element The pair of elements are usually connected to each other to prevent the removal of the access blocking member to prevent the medicine from being discharged from the compartment of the bag body, and the weak seal portion by the pressure from the outside. When the door is opened, the connection is released by the fluid pressure generated in the compartment of the bag body at that moment, and the removal of the access blocking member from the outlet member is allowed.

  According to the medicine bag configured as described above, in a state where the normal weak seal portion is not opened, the pair of elements of the cover member are connected to each other to prevent the access blocking member from being removed from the discharge port member. Therefore, the access blocking member is provided so as to cover the discharge port of the discharge port member. Thereby, access from the outside to the discharge port of the puncture needle or the like of the infusion set is blocked, and unmixed medicine is blocked from being discharged from the compartment of the bag body.

  In addition, when the weak seal portion is opened due to external pressure, different types of drugs are mixed in the compartment, and at the same time, the fluid pressure generated in the compartment of the bag body connects the pair of elements of the cover member. Is released. Thereby, removal of the access blocking member from the outlet member is allowed. Next, when the access blocking member is removed from the discharge port member, the discharge port can be accessed from the outside. Finally, by connecting the puncture needle of the infusion set to the discharge port, the mixed medicine is discharged from the compartment of the bag body to the outside.

  In the medicine bag of the configuration according to the present invention, even if the cover member is removed with the weak seal portion opened, the cover member is removed from the outlet member with the weak seal portion not opened. However, the access blocking member is attached to the discharge port member. Therefore, it is impossible to access the discharge port of the discharge port member with only the cover member removed, and in order to access the discharge port, it is necessary to further remove the access blocking member from the discharge port member.

  In this way, since the medicine cannot be discharged from the discharge port unless the access blocking member is removed from the discharge port member, it is determined whether or not the drug is mixed when the access blocking member is removed from the discharge port member. An opportunity to confirm can be given to the user. Therefore, whether or not the access blocking member is removed from the outlet member serves as a check function for the user to prevent unmixed medicine from being discharged out of the bag body compartment. The user's attention can be drawn so that the correct operation is performed.

  In the present invention, preferably, the access blocking member is attached to the outlet member in a tamper-proof manner.

  In the thus configured medicine bag, the access blocking member is attached to the discharge port member in a tamper-proof manner, that is, once the access blocking member is removed, it is discharged in the same state as before the access blocking member is removed. It is mounted so that it cannot be attached to the outlet member and is configured so that it can be seen visually whether the access blocking member has been removed previously. As described above, if a plurality of drugs are mixed in advance, the properties of the mixed drugs may change with time, so the access blocking member may have been removed from the outlet member before. If it is known, the user can be given an opportunity to confirm whether or not the property of the medicine has changed. Therefore, whether or not the access blocking member is removed from the discharge port member serves as a check function for the user to prevent the medicine that has changed over time from being discharged from the compartment of the bag body. As a result, the user's attention can be further raised so that the correct operation is performed.

  In the present invention, the access blocking member preferably includes a lid member that covers the discharge port of the discharge port member, and a tamper seal that is bonded to the lid member and the discharge port member. A peripheral extension extending over the tamper seal to cover at least a portion.

  In the present invention, it is preferable that the access blocking member has a lid portion that covers the discharge port of the discharge port member and a lid extension portion that extends from the lid portion, and the cover member includes the access blocking member that is the discharge port. It has a lid engaging portion that engages with the lid extension to prevent it from being removed from the member.

  As described above, the medicine bag according to the present invention can alert the user so that the medicine bag is of a different type and is operated correctly.

  Hereinafter, an embodiment of a medicine bag according to the present invention will be described with reference to the accompanying drawings.

  First, with reference to FIG. 1 thru | or FIG. 6, 1st Embodiment of the chemical | medical agent bag by this invention is described. 1 is a front view showing a drug bag according to a first embodiment of the present invention, FIG. 2 is a sectional view taken along line II-II in FIG. 1, and FIG. 3 is a drug bag with a cover member removed. FIG. 4 is a bottom view showing the drug bag, FIG. 5 is a sectional view when the pair of elements of the cover member is released, and FIG. 6 is a state where the cover member and the access blocking member are removed. It is an expanded front sectional view showing a medicine bag.

  As shown in FIG.1 and FIG.2, the chemical | medical agent bag 1 which is the 1st Embodiment of this invention has the bag main body 2 formed with the flexible raw material. The bag body 2 is formed in a substantially flat rectangular shape extending in the longitudinal direction A, and has a structure in which two films 4 are bonded together. The material of the film 4 is polyethylene, polypropylene or the like usually used for medical applications, and the thickness thereof is, for example, 250 microns. The periphery of the bag body 2 is pressurized and sealed at a temperature sufficiently higher than the softening temperature of the film 4 (for example, 145 ° C. in the case of polyethylene) to form a strong seal portion 6 and an internal cavity inside is doing. Further, the intermediate portion in the longitudinal direction A of the bag body 2 is pressurized and sealed at a temperature slightly higher than the softening temperature of the film 4 (for example, 120 ° C. in the case of polyethylene), and crosses the bag body 2 in the width direction B. The weak seal part 8 is comprised. The strong seal portion 6 and the weak seal portion 8 constitute a first compartment 10 and a second compartment 12 in the internal cavity of the bag body 2, and the weak seal portion 8 is composed of the first compartment 10 and the second compartment. The room 12 is partitioned. Different types of drugs are sealed in the first compartment 10 and the second compartment 12. The strong seal portion 6 remains sealed when a user such as a nurse or a nurse strongly pressurizes the medicine in the first compartment 10 from the outside of the bag body 2 containing the medicine on a table or the like. Has strength. On the other hand, the weak seal portion 8 has only a strength that allows at least a part of the weak seal portion 8 to be peeled off when the operation described above is performed. In order to facilitate opening of the weak seal portion 8 and to ensure a connection release response due to the liquid pressure of the cover member 20, the second compartment 12 is formed as a compartment having a smaller capacity than the first compartment 10. It is preferable. The strong seal portion 22 has a suspending hole 13 for suspending the drug bag 1 on an infusion stand or the like on the first compartment 10 side. Hereinafter, in the longitudinal direction A, the first compartment 10 side is referred to as an upward direction, and the second compartment 12 side is referred to as a bottom direction.

  As shown in FIGS. 1 and 3, the drug bag 1 further includes a discharge port member 16 that is attached to the bag body 2 and that opens to the second compartment 12 to form a discharge port 14 that discharges the drug to the outside. is doing. The discharge port member 16 includes a tubular member 16a that is hermetically bonded to the bag body 2 so as to communicate with the second compartment 12, and a cap member 16b that is bonded to the tubular member 16a on the opposite side of the bag body 2. A rubber plug 16c is sandwiched and attached between the tubular member 16a and the cap member 16b so as to close the discharge port 14. The tubular member 16a is preferably a plastic material compatible with the material of the drug bag 10, for example, polyethylene. The cap member 16b has an opening 16d constituting the end of the discharge port 14, and an annular peripheral portion 16e disposed around the opening 16d, and the plug 16c is exposed through the opening 16d. Thereby, the plug 16c can pierce the puncture needle of the infusion set for supplying the medicine in the medicine bag 1 at the time of instillation. The cap member 16b is preferably colored to indicate the type of drug.

  As shown in FIGS. 1 and 3, the drug bag 1 further includes an access blocking member 18 that is provided so as to cover the discharge port 14 of the discharge port member 16 and blocks access from the outside. The access blocking member 18 includes a lid member 18 a that covers the outlet 14 of the outlet member 16, and a tamper seal 18 b that is bonded to the lid member 18 a and the outlet member 16. Specifically, one surface of the tamper seal 18 b is bonded to the peripheral portion 16 e of the discharge port member 16 in a tamper-proof manner, and the lid member 18 a is bonded to the other surface so as to cover the discharge port 14. The tamper seal 18b has, for example, a two-layer structure of a PET layer having a thickness of 50 μm and a sealant layer having a thickness of 30 μm, and the sealant layer is preferably heat-sealed to the peripheral portion 16e. The tamper seal 18b has a seal extension 18c that extends beyond the periphery 16e to peel it away from the periphery 16e. The lid member 18a has a disk shape, and has an outer diameter smaller than the outer diameter of the peripheral portion 16e so that a portion bonded to the peripheral portion 16e of the tamper seal 18b is exposed. The thickness and material of the lid member 18a are selected so that the puncture needle of the infusion set does not pass through, and the material is, for example, polystyrene (PS), PET, PP, aluminum or the like.

  As shown in FIGS. 1, 2, and 5, the medical solution bag 1 further includes a cover member 20 that covers the access blocking member 18 and prevents the access blocking member 18 from being removed from the discharge port member 16. The cover member 20 has a pair of elements 20a and 20b attached so as to sandwich a part of the second compartment 12 in which the discharge port member 16 and the discharge port of the bag body 2 are formed from both sides. The pair of elements 20a and 20b includes at least one of an engaging portion 20c that can be engaged with a portion of the second compartment 12 of the bag body 2, a tubular intermediate portion 20d that covers the discharge port member 16, and a tamper seal 18b. A peripheral extension 20e extending on the tamper seal 18b radially inward from the bottom end of the intermediate part 20d so as to cover the part, and a connecting part 20f for releasably connecting the pair of elements 20a, 20b to each other have. The pair of elements 20a and 20b are normally connected to each other by a connecting portion 20f to prevent the access blocking member 18 from being removed from the discharge port member 16, but the pair of elements 20a and 20b is caused by external pressure. When the weak seal portion 6 is opened, the connection can be released by the fluid pressure generated in the first compartment 12 of the bag body 2 at that moment, so that the access blocking member 18 is detached from the discharge port member 16. Is acceptable.

  The intermediate part 20d preferably has a window 20g so that the color of the cap member 16b can be seen from the outside. The peripheral extension 20e extends on the tamper seal 18b, thereby preventing the tamper seal 18b from being peeled off from the peripheral portion 16e of the discharge port member 16. In the present embodiment, the peripheral extension 20e is annular, and the lid member 18a is exposed from the annular peripheral extension 20e. Further, the connecting portion 20f of the present embodiment includes a male member 20h and a female member 20i provided on both sides of one element 20a, and a male member 20h and a female member 20i provided on the other side. The male member 20h and the female member 20i of 20a are each comprised and arrange | positioned so that attachment / detachment with the female member 20 and male member 20h of the other element 20b is mutually possible.

  Next, the operation of the drug bag according to the first embodiment of the present invention will be described.

  As shown in FIGS. 1 and 2, normally, when the weak seal portion 8 is not opened, the pair of elements 20a and 20b of the cover member 20 are attached to the discharge port member 16 in a state of being connected to each other, The lid member 18a of the access blocking member 18 covers the plug 16c. Therefore, the puncture needle of the infusion set cannot be inserted into the plug 16c. As a result, unmixed medicine is prevented from being discharged.

  As shown in FIG. 5, when the weak seal portion 8 is opened by external pressure on the medicine in the first compartment 10, the medicine in the first compartment 10 moves vigorously into the second compartment 12. The connection of the pair of elements 20a and 20b of the cover member 20 is released by the fluid pressure generated in the compartments 10 and 12 of the bag body 2 at that moment. Accordingly, the cover member 20 can be removed from the discharge port member 16. Further, the opening of the weak seal portion 8 mixes the medicine in the first compartment 10, the medicine in the second compartment 12, and the medicine in the first compartment 10. Next, the tamper seal 18b is peeled off together with the lid member 18a by holding the seal extension 18c of the tamper seal 18b. Thereby, the plug 16c is exposed as shown in FIG. Finally, by inserting the puncture needle 22 of the infusion set into the plug 16c, the medicine in the first compartment 10 and the medicine in the second compartment 12 are mixed and discharged from the discharge port 14.

  Even if the cover member 20 is forcibly removed from the discharge port member 16 in a state where the weak seal portion 8 is not opened, the access blocking member 18 is still attached to the discharge port member 16 as shown in FIG. The plug 16c is not exposed. Accordingly, the puncture needle 22 of the infusion set cannot be pierced into the plug 16c only by removing the cover member 20. That is, when the puncture needle 22 is inserted into the plug 16c, the tamper seal 18b must be removed from the discharge port member 16, as shown in FIG. At this time, it is possible to call the user's attention so as to confirm whether or not the medicine in the first compartment 10 and the medicine in the second compartment 12 are mixed.

  If there is no access blocking member 18 and the cover member 20 is removed from the discharge port member, the user of the drug bag 1 opens the weak seal portion 8 unless the special care is taken. It will be recognized as being mixed. On the other hand, in the medicine bag 1 according to the present embodiment, since the operation of removing the access blocking member 18 is necessarily required, the cover member 20 determines whether or not the weak seal portion 8 is opened and the medicine is mixed. It is possible to confirm again at the time of the operation of removing the access blocking member without relying only on the confirmation that the access member has been removed. That is, it is possible to alert the user so as to confirm whether or not the weak seal portion is opened. Thereby, it is possible to further reduce the risk of administering an unmixed drug to a patient.

  Next, with reference to FIG.7 and FIG.8, the chemical | medical agent bag which is the 2nd Embodiment of this invention is demonstrated. The medicine bag 30 according to the second embodiment of the present invention has the same configuration as that of the medicine bag 1 according to the first embodiment, except that the access blocking member and the cover member are partially different. Accordingly, the same constituent elements as those in the first embodiment are denoted by the same reference numerals, the description thereof is omitted, and only different parts will be described below. FIG. 7 is an enlarged front sectional view showing a medicine bag according to the second embodiment of the present invention, and FIG. 8 is an enlarged front sectional view of the medicine bag with a cover member removed.

  As shown in FIG. 7, the access prevention member 32 of the medicine bag 30 has a lid portion 32a that covers the discharge port 14 of the discharge port member 16, and a lid extension portion 32b that extends from the lid portion 32a. Specifically, the lid portion 32 a is in the form of an outer cap that covers the entire cap member 16 b of the discharge port member 16. The bottom portion 32c of the outer cap 32a facing the plug 16c exposed from the discharge port member 16 is closed, and the thickness and material of the bottom portion 32a are selected so that the puncture needle of the infusion set does not pass through. , Polystyrene (PS), PET, PP and the like. The lid extension 74 includes a flange provided to extend radially outward from the upper portion 32d of the outer cap 32a. Although not shown, the access blocking member 32 may be attached to the outlet member 16 in a tamper-proof manner.

  Further, the cover member 34 of the medicine bag 30 has a pair of elements 34a and 34b, and the pair of elements 34a and 34b is used instead of the peripheral extension 20e of the cover member 20 of the medicine bag 1 of the first embodiment. A lid engaging portion 34c extending radially inward from the intermediate portion 20d and engaging the lid extension portion 32b so as to prevent the outer cap 32a from being removed from the outlet port 16 in the bottom direction. Yes.

  Next, the operation of the drug bag according to the second embodiment of the present invention will be described.

  As shown in FIG. 7, normally, when the weak seal portion 8 is not opened, the pair of elements 34a and 34b of the cover member 34 are attached to the discharge port member 16 in a state of being connected to each other, and the access blocking member A lid portion (outer cap) 32a of 32 covers the plug 16c. Therefore, the puncture needle of the infusion set cannot be inserted into the plug 16c. As a result, unmixed medicine is prevented from being discharged.

  As shown in FIG. 8, when the weak seal portion 8 is opened by external pressure on the medicine in the first compartment 10, the medicine in the first compartment 10 moves vigorously into the second compartment 12. The connection of the pair of elements 34a, 34b of the cover member 34 is released by the fluid pressure generated in the compartments 10, 12 of the bag body 2 at that moment. Accordingly, the cover member 34 can be removed from the discharge port member 16. Further, the opening of the weak seal portion 8 mixes the medicine in the first compartment 10, the medicine in the second compartment 12, and the medicine in the first compartment 10. Next, the outer cap 32 a is moved in the bottom direction, and the outer cap 32 a is removed from the discharge port member 16. Thereby, the plug 16c is exposed. Finally, by piercing the plug 16c with the puncture needle of the infusion set, the medicine in the first compartment 10 and the medicine in the second compartment 12 are discharged from the discharge port 14 in a mixed state.

  Even if the cover member 34 is forcibly removed from the discharge port member 16 in a state where the weak seal portion 8 is not opened, the access blocking member 32 is still attached to the discharge port member 16 as shown in FIG. The plug 16c is not exposed. Accordingly, the puncture needle of the infusion set cannot be pierced into the plug 16c only by removing the cover member 34. That is, when the puncture needle is inserted into the plug 16c, the outer cap 32a must be removed from the outlet member 16 (see FIG. 6). At this time, it is possible to call the user's attention so as to confirm whether or not the medicine in the first compartment 10 and the medicine in the second compartment 12 are mixed.

Although the embodiments of the present invention have been described above, the present invention is not limited to the above-described embodiments, and various modifications are possible within the scope of the invention described in the claims. Needless to say, these are also included within the scope of the present invention.
Although the peripheral extension 20e of the first embodiment is annular (see FIG. 4), the tamper seal 18b must not be peeled off from the peripheral portion 16e with the cover member 20 attached to the discharge port member 16. For example, the shape of the peripheral extension 20e is arbitrary. For example, as shown in FIG. 9, the peripheral extension 20e ′ may be interrupted in the circumferential direction.
In the first embodiment, the tamper seal 18b of the access blocking member 18 is disposed between the lid member 18a and the plug 16c. However, the lid member 18a may be disposed between the tamper seal and the plug 16c.
In the second embodiment, the lid member 32a of the access blocking member 32 is in the form of an outer cap and the lid extension portion 32b extending from the outer cap 32a is a flange. However, the lid member 32a is removed from the discharge port member 16. If the lid extension portion 32b engages with the lid extension portion 34c of the cover member 34 so as to prevent removal, the shapes of the lid member 32a, the lid extension portion 32b, and the lid engagement portion 34c are arbitrary.
Moreover, in the said embodiment, although the connection part 20f of the cover member was made into the mutually detachable male member 20h and the female member 20i provided in each of a pair of elements 20a and 20b, only a male member is used for one element It is also possible to provide only the female member on the other element 20b. The form of the connecting portion 20 is not limited to that shown in FIG. 5, and when the weak seal portion 6 is opened by external pressure, the connection portion 20 is generated in the first compartment 12 of the bag body 2 at that moment. It is optional as long as the connection can be released by fluid pressure.

It is a front view which shows the chemical | medical agent bag which is the 1st Embodiment of this invention. It is sectional drawing seen along the II-II line of FIG. It is an expanded front sectional view showing a medicine bag in the state where a cover member was removed. It is a bottom view showing a medicine bag. It is sectional drawing when a connection of a pair of element of a cover member is cancelled | released. It is a front view of a medicine bag when an access blocking member is removed. It is an expanded front sectional view showing a medicine bag which is a 2nd embodiment of the present invention. It is an expanded front sectional view of the medicine bag of a 2nd embodiment in the state where the cover member was removed. It is a bottom view which shows the modification of the cover member of the chemical | medical agent bag of the 1st Embodiment of this invention.

Explanation of symbols

DESCRIPTION OF SYMBOLS 1 Drug bag 2 Bag main body 8 Weak seal part 10 1st compartment 12 2nd compartment 14 Outlet 16 Outlet member 18 Access blocking member 18a Lid member 18b Tamper seal 20 Cover member 20a, 20b A pair of element 20e Periphery extension part 32 Access blocking member 32a Lid member 32b Lid extension 34 Cover members 34a, 34b A pair of elements 34c Lid engaging part

Claims (4)

A drug bag having a plurality of compartments and mixing and using medicines enclosed in these compartments,
A bag body that is formed of a flexible material, divides an internal cavity into a plurality of compartments by a weak seal portion, and a different type of medicine is enclosed in each compartment;
A discharge port member that is attached to the bag body and that opens to one of the plurality of compartments and constitutes a discharge port for discharging the medicine to the outside;
An access blocking member provided so as to cover the discharge port of the discharge port member and blocking access from the outside;
A cover member that covers the access blocking member and prevents the access blocking member from being removed from the outlet member,
The cover member has a pair of elements attached so as to sandwich a part of the compartment in which the discharge port member and the discharge port of the bag main body are formed from both sides. It is connected to each other to prevent the access blocking member from being removed to prevent the medicine from being discharged from the compartment of the bag body to the outside. The medicine bag is configured so that the connection is released by the fluid pressure generated in the compartment and the access blocking member is allowed to be removed from the outlet member.   The drug bag according to claim 1, wherein the access blocking member is attached to the discharge port member in a tamper-proof manner. The access blocking member has a cover member that covers the discharge port of the discharge port member, and a tamper seal bonded to the cover member and the discharge port member.
The drug bag according to claim 2, wherein the cover member has a peripheral extension extending on the tamper seal so as to cover at least a part of the tamper seal. The access blocking member has a lid portion that covers the outlet of the outlet member, and a lid extension that extends from the lid portion,
The medicine bag according to claim 1 or 2, wherein the cover member has a lid engaging portion that engages with the lid extension portion so as to prevent the access blocking member from being removed from the discharge port member. .

Images